| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 357 |
| 1 | BLINATUMOMAB | 343 |
| 2 | METHOTREXATE | 307 |
| 3 | DEXAMETHASONE | 291 |
| 4 | DEXAMETHASONE 1.5 MG | 286 |
| 5 | CYCLOPHOSPHAMIDE | 272 |
| 6 | CYTARABINE | 237 |
| 7 | FLUDARABINE PHOSPHATE | 202 |
| 8 | PREDNISONE | 174 |
| 9 | IMATINIB | 124 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PHENOL 0.6% ANESTHETIC ORAL RINSE | 1 | 0.0833 |
| 1 | BLINATUMOMAB | 343 | 0.0777 |
| 2 | INOTUZUMAB OZOGAMICIN | 42 | 0.0373 |
| 3 | PONATINIB HYDROCHLORIDE | 87 | 0.0234 |
| 4 | MOXETUMOMAB PASUDOTOX | 1 | 0.0222 |
| 5 | THROMBIN TOPICAL RECOMBINANT | 1 | 0.0185 |
| 6 | IDARUBICIN HYDROCHLORIDE | 6 | 0.0179 |
| 7 | DEFIBROTIDE SODIUM | 31 | 0.0174 |
| 8 | DAUNORUBICIN HYDROCHLORIDE | 9 | 0.0153 |
| 9 | CLOFARABINE | 36 | 0.0151 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 428 |
| 1 | Alkylating Drug [EPC] | 349 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 307 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 270 |
| 4 | Azole Antifungal [EPC] | 94 |
| 5 | Topoisomerase Inhibitor [EPC] | 83 |
| 6 | Kinase Inhibitor [EPC] | 78 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 72 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 71 |
| 9 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 64 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 42 | 0.0373 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 5 | 0.0139 |
| 2 | Interleukin-6 Antagonist [EPC] | 2 | 0.0102 |
| 3 | Immunoglobulin G [EPC] | 28 | 0.0050 |
| 4 | Asparagine-specific Enzyme [EPC] | 34 | 0.0046 |
| 5 | Echinocandin Antifungal [EPC] | 11 | 0.0034 |
| 6 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 2 | 0.0033 |
| 7 | Alkylating Drug [EPC] | 349 | 0.0025 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 22 | 0.0022 |
| 9 | Lipid Emulsion [EPC] | 3 | 0.0021 |